Abstract:We previously demonstrated that the NO-receptor soluble guanylyl cyclase (GC1) has the ability to transnitrosate other proteins in a reaction that involves, in some cases, oxidized Thioredoxin 1 (oTrx1). This transnitrosation cascade was established in vitro and we identified by mass spectrometry and mutational analysis Cys 610 (C610) of GC1 α–subunit as a major donor of S–nitrosothiols (SNO). To assay the relevance of GC1 transnitrosation under physiological conditions and in oxidative pathologies, we studied a knock–in mouse in which C610 was replaced with a serine (KI αC610S) under basal or angiotensin II (Ang II)–treated conditions. Despite similar GC1 expression and NO-stimulated cGMP-forming activity, the Ang II–treated KI mice displayed exacerbated oxidative pathologies including higher mean arterial pressure and more severe cardiac dysfunctions compared to the Ang II–treated WT. These phenotypes were associated with a drastic decrease in global S-nitrosation and in levels of SNO-Trx1 and SNO-RhoA in the KI mice. To investigate the mechanism underlying the dysregulation of blood pressure despite an intact NO–cGMP axis, pressure myography and in vivo intravital microscopy were conducted to analyze the vascular resistance tone. Both approaches indicated that, even in the absence of oxidative stress, the single mutation C610S led to a significant deficiency in acetylcholine–induced vasorelaxation while smooth muscle relaxation in response to NO remained unchanged. These findings indicate that the C610S mutation uncoupled the two NO signaling pathways involved in the endothelium and smooth muscle vasorelaxation and suggest that GC1-dependent S–nitrosation is a key player in endothelium–derived hyperpolarization.

A novel insight into the heme and NO/CO binding mechanism of the alpha subunit of human soluble guanylate cyclase

Structural and functional insights into the heme-binding domain of the human soluble guanylate cyclase α2 subunit and heterodimeric α2β1

Efficient Expression of Human Soluble Guanylate Cyclase in Escherichia Coli and Its Signaling-Related Interaction with Nitric Oxide.

Probing the Molecular Mechanism of Human Soluble Guanylate Cyclase Activation by NO in Vitro and in Vivo

Structural insights into the mechanism of human soluble guanylate cyclase

A Novel Insight into the Molecular Mechanism of Human Soluble Guanylyl Cyclase Focused on Catalytic Domain in Living Cells

Human Soluble Guanylate Cyclase As A Nitric Oxide Sensor for No-Signalling Reveals A Novel Function of Nitrite Reductase

The Roles of Cysteines in the Heme Domain of Human Soluble Guanylate Cyclase

Dynamic change of heme environment in soluble guanylate cyclase and complexation of NO-independent drug agents with H-NOX domain

Structural Basis and Molecular Mechanism of Soluble Guanylate Cyclase in NO-signaling Transduction

Activation Mechanism of Human Soluble Guanylate Cyclase by Stimulators and Activators

Entry of Water into the Distal Heme Pocket of Soluble Guanylate Cyclase Β1 H-NOX Domain Alters the Ligated CO Structure: a Resonance Raman and in Silico Simulation Study

The Process of S-nitrosation in Sgc Β1(1–194) Revealed by Infrared Spectroscopy

GAPDH delivers heme to soluble guanylyl cyclase

Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase

Heat Shock Protein 90 Associates with the Per-Arnt-Sim Domain of Heme-free Soluble Guanylate Cyclase

Heat shock protein 90 regulates soluble guanylyl cyclase maturation by a dual mechanism

Complex Interplay of Heme-Copper Oxidases with Nitrite and Nitric Oxide

Soluble guanylyl cyclase, the NO-receptor, regulates endothelium-dependent vascular relaxation via its transnitrosation activity.

Per-ARNT-Sim domains in nitric oxide signaling by soluble guanylyl cyclase

Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains.